返回 Agenda
Closing Session: Panel Discussion
Session Chair(s)
Arthur A. Levin, PhD
Senior Consultant
Levin BioScience, United States
Closing Session: Panel Discussion
Speaker(s)
Panelist
Paul C. Brown, PhD
FDA, United States
Associate Director for Pharmacology and Toxicology, OND, CDER
Panelist
Scott Henry, PhD
Ionis Pharmaceuticals, Inc., United States
Vice President, Nonclinical Development
Panelist
René Thürmer, PhD
Federal Institute for Drugs and Medical Devices, Germany
Deputy Head of the Unit Pharmaceutical Biotechnology BfArM
Panelist
G. Susan Srivatsa, PhD
ElixinPharma, United States
President
Panelist
Hobart Rogers, PharmD, PhD
FDA, United States
Pharmacologist
Panelist
Saraswathy V. Nochur, PhD, MSc
Alnylam Pharmaceuticals, United States
Chief Regulatory Officer